Definitive Healthcare Corp. (DH) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 12, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 10, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the DH SEC filings page.
Definitive Healthcare Corp. (DH) reported $232.7M in revenue over the twelve months to Jun 30, 2026, down 5.0% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Positive free cash flow persists despite deep accounting losses, while shrinking assets and rising leverage expose a less forgiving balance sheet.
The gap between FY2025's-$139M net loss and$54M operating cash flow indicates that reported earnings are being pulled down by charges that do not consume cash immediately, rather than reflecting a matching cash deficit.
Revenue fell to
The balance sheet is contracting faster than debt is being reduced: total assets fell to
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Definitive Healthcare Corp.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Definitive Healthcare Corp. has an operating margin of -92.9%, meaning the company loses $93 on every $100 of revenue. This results in a profitability score of 13/100. This is up from -281.8% the prior year.
Definitive Healthcare Corp.'s revenue declined 4.2% year-over-year, from $252.2M to $241.5M. This contraction results in a growth score of 24/100.
Definitive Healthcare Corp. has a moderate D/E ratio of 0.41. This balance of debt and equity financing earns a leverage score of 64/100.
Definitive Healthcare Corp.'s current ratio of 1.64 indicates adequate short-term liquidity, earning a score of 47/100. The company can meet its near-term obligations, though with limited headroom.
Definitive Healthcare Corp. converts 15.3% of revenue into free cash flow ($37.1M). This strong cash generation earns a score of 80/100.
Definitive Healthcare Corp. posts a -36.7% return on equity (ROE), meaning it loses $37 for every $100 of shareholders' equity. This results in a returns score of 14/100. This is up from -68.0% the prior year.
Definitive Healthcare Corp. scores -1.81, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($112.1M) relative to total liabilities ($356.5M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Definitive Healthcare Corp. passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
Definitive Healthcare Corp. reported a net loss of $138.9M while generating $53.8M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.
Definitive Healthcare Corp. reported an operating loss of $224.3M against $11.3M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
Definitive Healthcare Corp. generated $55.2M in revenue in Q2 2026. This represents a decrease of 9.1% from the same quarter a year earlier. Against the prior quarter it is down 1.3%.
Definitive Healthcare Corp.'s EBITDA was $1.8M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 62.9% from the same quarter a year earlier. Against the prior quarter it is up 100.9%.
Definitive Healthcare Corp. reported -$5.4M in net income in Q2 2026. This represents an increase of 28.2% from the same quarter a year earlier. Against the prior quarter it is up 96.1%.
Definitive Healthcare Corp. earned -$0.05 per diluted share (EPS) in Q2 2026. This represents an increase of 28.6% from the same quarter a year earlier. Against the prior quarter it is up 96.2%.
Cash & Balance Sheet
Definitive Healthcare Corp. generated $8.5M in free cash flow in Q2 2026, representing cash available after capex. This represents an increase of 21.4% from the same quarter a year earlier. Against the prior quarter it is up 1.8%.
Definitive Healthcare Corp. held $170.9M in cash against $151.9M in long-term debt as of Q2 2026.
Not reported for Q2 2026.
Margins & Returns
Definitive Healthcare Corp.'s gross margin was 73.5% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is down 3.3 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.0 percentage points.
Definitive Healthcare Corp.'s operating margin was -12.2% in Q2 2026, reflecting core business profitability. This is down 5.4 percentage points from the same quarter a year earlier.
Definitive Healthcare Corp.'s net profit margin was -9.8% in Q2 2026, showing the share of revenue converted to profit. This is up 2.6 percentage points from the same quarter a year earlier.
Definitive Healthcare Corp.'s ROE was -2.9% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is down 1.0 percentage points from the same quarter a year earlier. Against the prior quarter it is up 69.8 percentage points.
Capital Allocation
Definitive Healthcare Corp. invested $6.8M in research and development in Q2 2026. This represents a decrease of 15.2% from the same quarter a year earlier. Against the prior quarter it is up 4.0%.
Definitive Healthcare Corp. repurchased no shares in Q2 2026. This represents a decrease of 100.0% from the same quarter a year earlier.
Definitive Healthcare Corp. invested $2.9M in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 28.3% from the same quarter a year earlier. Against the prior quarter it is down 8.1%.
DH Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $55.2M-9.1% | $55.9M-5.5% | $61.5M-1.2% | $60.0M-4.2% | $60.8M-4.7% | $59.2M-6.8% | $62.3M-5.5% | $62.7M-4.0% |
| Cost of Revenue | $14.7M+3.7% | $14.3M-7.5% | $14.6M-0.4% | $14.1M+2.8% | $14.1M+6.4% | $15.4M+17.8% | $14.7M-33.8% | $13.7M+57.8% |
| Gross Profit | $40.5M-13.0% | $41.6M-4.8% | $46.9M-1.5% | $46.0M-6.2% | $46.6M-7.6% | $43.8M-13.1% | $47.6M-10.9% | $49.0M-8.2% |
| R&D Expenses | $6.8M-15.2% | $6.5M-30.1% | $10.0M+10.8% | $7.6M+3.7% | $8.0M-21.3% | $9.3M-8.2% | $9.0M-22.4% | $7.3M-32.3% |
| SG&A Expenses | $10.8M-14.7% | $12.1M-1.5% | $14.3M+68.4% | $12.4M+8.9% | $12.7M+1.2% | $12.3M-27.3% | $8.5M-48.7% | $11.4M-21.9% |
| Operating Income | -$6.7M-61.8% | -$201.3M-8.9% | -$26.6M+73.3% | -$8.7M+96.1% | -$4.2M+98.9% | -$184.8M-1037.2% | -$99.6M-887.7% | -$225.4M+23.7% |
| EBITDA | $1.8M-62.9% | -$200.3M-8.7% | -$42.0M+64.0% | $388K+100.2% | $4.8M+101.3% | -$184.2M-1073.6% | -$116.8M-315.2% | -$215.9M+24.4% |
| Interest Expense | $2.6M-12.1% | $2.6M+8.1% | $2.9M-18.3% | $3.0M-20.0% | $3.0M-20.5% | $2.4M-36.2% | $3.5M-10.0% | $3.7M-3.8% |
| Income Tax | -$345K-175.7% | -$3.4M+68.4% | -$53K+99.1% | $524K+103.8% | $456K+102.1% | -$10.9M-1295.6% | -$5.9M-601.7% | -$13.7M+21.7% |
| Net Income | -$5.4M+28.2% | -$138.6M-29.3% | -$9.3M+84.2% | -$14.8M+88.7% | -$7.6M+96.5% | -$107.2M-1026.6% | -$59.1M-477.3% | -$130.9M+23.7% |
| EPS (Basic) | -$0.05+28.6% | -$1.32-38.9% | -$0.10+80.8% | -$0.14+87.5% | -$0.07+96.1% | -$0.95-1087.5% | -$0.52-642.9% | -$1.12+25.3% |
| EPS (Diluted) | -$0.05+28.6% | -$1.32-38.9% | -$0.10+80.8% | -$0.14+87.5% | -$0.07+96.1% | -$0.95-1087.5% | -$0.52-642.9% | -$1.12+25.3% |
| Diluted Shares (Avg) | 106M-0.9% | 105M-7.2% | N/A | 104M-10.8% | 107M-9.3% | 113M-4.0% | N/A | 116M+1.6% |
DH Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $496.8M-35.5% | $514.7M-36.3% | $735.5M-32.5% | $755.5M-36.1% | $770.1M-45.9% | $808.7M-55.3% | $1.1B-40.3% | $1.2B-35.1% |
| Current Assets | $240.1M-3.7% | $245.8M-10.1% | $257.6M-30.4% | $246.3M-33.2% | $249.2M-32.3% | $273.4M-27.8% | $370.2M-6.0% | $368.7M-1.8% |
| Cash & Equivalents | $170.9M+111.0% | $157.6M+48.6% | $163.6M+55.3% | $108.3M-21.3% | $81.0M-33.0% | $106.1M+0.1% | $105.4M-19.5% | $137.6M+77.7% |
| Short-Term Investments | $12.7M-87.7% | $20.4M-78.4% | $17.3M-90.7% | $77.6M-53.7% | $103.2M-41.2% | $94.6M-50.0% | $184.8M+4.3% | $167.8M-26.9% |
| Accounts Receivable | $31.0M-17.4% | $38.9M-9.3% | $52.0M-2.3% | $34.4M-3.9% | $37.5M-15.1% | $42.9M-24.2% | $53.2M-10.2% | $35.8M-13.4% |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill | $0-100.0% | $0-100.0% | $197.2M-49.9% | $216.8M-55.8% | $216.8M-69.8% | $216.8M-80.0% | $393.3M-63.4% | $490.3M-54.3% |
| Total Liabilities | $309.0M-13.9% | $324.0M-13.1% | $356.5M-26.1% | $365.9M-24.7% | $358.9M-33.1% | $372.8M-39.4% | $482.2M-23.1% | $486.1M-21.1% |
| Current Liabilities | $129.1M-14.7% | $140.4M-10.0% | $156.8M-2.7% | $153.9M+3.9% | $151.3M-1.5% | $156.1M-5.4% | $161.2M-5.6% | $148.2M+0.7% |
| Non-Current Liabilities | $179.9M-13.4% | $183.6M-15.2% | $199.7M-37.8% | $212.0M-37.3% | $207.7M-45.7% | $216.7M-51.9% | $321.0M-29.6% | $337.9M-27.9% |
| Long-Term Debt | $151.9M-5.2% | $154.0M-5.2% | $156.1M-31.9% | $158.2M-32.0% | $160.3M-32.1% | $162.4M-32.1% | $229.4M-5.4% | $232.7M-5.4% |
| Total Equity | $187.9M-54.3% | $190.7M-56.3% | $379.0M-37.6% | $389.7M-44.0% | $411.2M-53.6% | $435.9M-63.5% | $607.2M-49.4% | $695.6M-42.2% |
| Retained Earnings | -$923.5M-22.3% | -$918.1M-22.8% | -$779.5M-21.7% | -$770.2M-32.4% | -$755.4M-67.6% | -$747.8M-215.6% | -$640.6M-181.6% | -$581.5M-167.7% |
Not reported in any period shown, so not listed: Inventory.
DH Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $11.5M+23.1% | $11.6M-55.6% | $2.7M-66.6% | $15.7M-19.3% | $9.3M-33.7% | $26.1M+57.1% | $8.1M+72.8% | $19.4M+104.8% |
| Depreciation & Amortization | $8.5M-5.1% | $1.0M+69.9% | $991K+88.4% | $9.1M-4.2% | $9.0M-4.3% | $591K+6.7% | $526K-6.4% | $9.5M-3.3% |
| Stock-Based Compensation | $5.3M-24.7% | $5.2M-28.7% | N/A | $6.7M+6.2% | $7.0M-21.1% | $7.3M-53.0% | N/A | $6.3M-47.5% |
| Capital Expenditures | $2.9M+28.3% | $3.2M-58.4% | $4.4M-59.3% | $2.3M+197.4% | $2.3M+459.3% | $7.7M+2797.0% | $10.9M+1735.2% | $767K+151.5% |
| Free Cash Flow | $8.5M+21.4% | $8.4M-54.5% | -$1.7M+37.8% | $13.4M-28.2% | $7.0M-48.6% | $18.4M+12.5% | -$2.8M-167.2% | $18.7M+103.3% |
| Investing Cash Flow | $4.9M+148.2% | -$6.2M-107.4% | $56.4M+314.5% | $24.1M+169.4% | -$10.2M-168.0% | $83.5M+447.6% | -$26.3M-148.3% | $9.0M+116.6% |
| Financing Cash Flow | -$3.0M+87.8% | -$10.9M+90.1% | -$3.9M+70.7% | -$12.5M-3.4% | -$24.7M-74.9% | -$109.7M-538.0% | -$13.4M-120.5% | -$12.1M-16.4% |
| Share Buybacks | $0-100.0% | $0-100.0% | $0-100.0% | $9.2M+14.8% | $19.1M+172.4% | $21.2M | $7.3M | $8.0M |
Not reported in any period shown, so not listed: Dividends Paid.
DH Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 73.5%-3.3pp | 74.5%+0.5pp | 76.2%-0.2pp | 76.6%-1.6pp | 76.7%-2.4pp | 73.9%-5.4pp | 76.4%-4.6pp | 78.2%-3.6pp |
| Operating Margin | -12.2%-5.4pp | -359.9% | -43.3% | -14.5% | -6.9% | -312.2% | -159.8% | -359.4% |
| Net Margin | -9.8%+2.6pp | -247.8% | -15.1%+79.7pp | -24.7% | -12.4% | -181.2% | -94.8%-79.3pp | -208.8% |
| Return on Equity | -2.9%-1.0pp | -72.7%-48.1pp | -2.5%+7.3pp | -3.8%+15.0pp | -1.8%+22.3pp | -24.6%-23.8pp | -9.7%-8.9pp | -18.8%-4.6pp |
| Return on Assets | -1.1%-0.1pp | -26.9%-13.7pp | -1.3%+4.1pp | -2.0%+9.1pp | -1.0%+14.0pp | -13.3%-12.7pp | -5.4%-4.9pp | -11.1%-1.7pp |
| Current Ratio | 1.86+0.2x | 1.750.0x | 1.64-0.7x | 1.60-0.9x | 1.65-0.8x | 1.75-0.5x | 2.300.0x | 2.49-0.1x |
| Debt-to-Equity | 0.81+0.4x | 0.81+0.4x | 0.410.0x | 0.41+0.1x | 0.39+0.1x | 0.37+0.2x | 0.38+0.2x | 0.33+0.1x |
| Asset Turnover | 0.110.0x | 0.110.0x | 0.080.0x | 0.080.0x | 0.080.0x | 0.070.0x | 0.060.0x | 0.050.0x |
| FCF Margin | 15.4%+3.9pp | 14.9%-16.1pp | -2.8%+1.6pp | 22.3%-7.4pp | 11.5%-9.8pp | 31.0%+5.3pp | -4.4%-10.7pp | 29.8%+15.7pp |
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Definitive Healthcare Corp. DH | FY2025 | $241.5M | -$138.9M | -57.5% | $112.1M | 40/100 |
| Talkspace, Inc. TALK | FY2025 | $228.9M | $7.8M | 3.4% | $870.6M | 55/100 |
| NRC Health NRC | FY2025 | $137.4M | $11.6M | 8.4% | $467.2M | 50/100 |
| OptimizeRx Corporation OPRX | FY2025 | $109.4M | $5.1M | 4.7% | $137.3M | 60/100 |
| So-Young International Inc. SY | FY2025 | $217.8M | -$34.6M | -15.9% | $272.7M | 33/100 |
| Spok Holdings, Inc SPOK | FY2025 | $139.7M | $15.9M | 11.4% | $222.8M | 54/100 |
Where Definitive Healthcare Corp. Ranks
Frequently Asked Questions
What is Definitive Healthcare Corp.'s annual revenue?
Definitive Healthcare Corp. (DH) reported $241.5M in total revenue for fiscal year 2025. This represents a -4.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Definitive Healthcare Corp.'s revenue growing?
Definitive Healthcare Corp. (DH) revenue declined by 4.2% year-over-year, from $252.2M to $241.5M in fiscal year 2025.
Is Definitive Healthcare Corp. profitable?
No, Definitive Healthcare Corp. (DH) reported a net income of -$138.9M in fiscal year 2025, with a net profit margin of -57.5%.
What is Definitive Healthcare Corp.'s EBITDA?
Definitive Healthcare Corp. (DH) had EBITDA of -$221.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Definitive Healthcare Corp. have?
As of fiscal year 2025, Definitive Healthcare Corp. (DH) had $163.6M in cash and equivalents against $156.1M in long-term debt.
What is Definitive Healthcare Corp.'s gross margin?
Definitive Healthcare Corp. (DH) had a gross margin of 75.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Definitive Healthcare Corp.'s operating margin?
Definitive Healthcare Corp. (DH) had an operating margin of -92.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Definitive Healthcare Corp.'s net profit margin?
Definitive Healthcare Corp. (DH) had a net profit margin of -57.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Definitive Healthcare Corp.'s return on equity (ROE)?
Definitive Healthcare Corp. (DH) has a return on equity of -36.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Definitive Healthcare Corp.'s free cash flow?
Definitive Healthcare Corp. (DH) generated $37.1M in free cash flow during fiscal year 2025. This represents a -19.2% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Definitive Healthcare Corp.'s operating cash flow?
Definitive Healthcare Corp. (DH) generated $53.8M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Definitive Healthcare Corp.'s total assets?
Definitive Healthcare Corp. (DH) had $735.5M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Definitive Healthcare Corp.'s capital expenditures?
Definitive Healthcare Corp. (DH) invested $16.7M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Definitive Healthcare Corp. spend on research and development?
Definitive Healthcare Corp. (DH) invested $34.8M in research and development during fiscal year 2025.
What is Definitive Healthcare Corp.'s current ratio?
Definitive Healthcare Corp. (DH) had a current ratio of 1.64 as of fiscal year 2025, which is generally considered healthy.
What is Definitive Healthcare Corp.'s debt-to-equity ratio?
Definitive Healthcare Corp. (DH) had a debt-to-equity ratio of 0.41 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Definitive Healthcare Corp.'s return on assets (ROA)?
Definitive Healthcare Corp. (DH) had a return on assets of -18.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Definitive Healthcare Corp.'s P/E ratio?
Definitive Healthcare Corp. (DH) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $112.1M as of Sep 12, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Definitive Healthcare Corp.'s price-to-sales ratio?
Definitive Healthcare Corp. (DH) trades at 0.5x sales, its market capitalization divided by revenue of $232.7M revenue, trailing 12 months to June 30, 2026. The market capitalization is $112.1M as of Sep 12, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Definitive Healthcare Corp.'s Altman Z-Score?
Definitive Healthcare Corp. (DH) has an Altman Z-Score of -1.81, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Definitive Healthcare Corp.'s Piotroski F-Score?
Definitive Healthcare Corp. (DH) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Definitive Healthcare Corp.'s earnings high quality?
Definitive Healthcare Corp. (DH) reported a net loss of $138.9M while generating $53.8M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Definitive Healthcare Corp. cover its interest payments?
Definitive Healthcare Corp. (DH) reported an operating loss of $224.3M against $11.3M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Definitive Healthcare Corp.?
Definitive Healthcare Corp. (DH) scores 40 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.